expected weight loss with tirzepatide What is the percentage for a patient on 5mg (glucagon-like peptide-1 receptor agonist) who has only lost 1kg in the first 2 months of treatment? Tirzepatide vs. Semaglutide for Weight

Hypertension (2020) 76(3):83948

While semaglutide is FDA-approved for weight loss under a different name, Mounjaro is currently approved for type 2 diabetes but is also being used off-label for obesity, with promising clinical results

Work with a healthcare provider to adjust the dosage based on your symptoms

The incretin hormone glucagonlike peptide 1 increases mitral cell excitability by decreasing conductance of a voltagedependent potassium channel

Youll get there

In the 2021 STEP-1 trial (1,961 adults with obesity or overweight), participants receiving semaglutide plus lifestyle intervention experienced a 14.9% mean weight loss after 68 weeks, while those on placebo lost only 2.4%